This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of various pharmacologically active molecules. Its structure, featuring a benzylpiperidine moiety, makes it valuable in the development of compounds targeting the central nervous system (CNS). It is often employed in the creation of potential drugs for neurological disorders, such as Alzheimer's disease, Parkinson's disease, and other conditions involving neurotransmitter modulation. Additionally, its trifluoroacetamide group enhances its stability and bioavailability, making it a suitable candidate for further chemical modifications in drug discovery pipelines. Researchers also explore its use in the design of receptor-specific ligands, particularly for dopamine and serotonin receptors, due to its ability to interact with these targets effectively.